Study on the clinical efficacy and mechanism of Sijun Wupi Decoction in the treatment of refractory ascites due to liver cirrhosis based on the spleen governing transportation and chemistry
Not Applicable
Recruiting
- Conditions
- Refractory ascites due to liver cirrhosis
- Registration Number
- ITMCTR2200005701
- Lead Sponsor
- Affiliated Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Meet the above-mentioned diagnostic criteria for refractory ascites due to liver cirrhosis;
(2) Aged over 18 years old;
(3) Sign the informed consent form.
Exclusion Criteria
(1) The patient is under 18 years old;
(2) Patients with non-refractory ascites due to liver cirrhosis;
(3) Patients with hepatocarcinoma, cardiogenic, tuberculosis and renal ascites;
(4) Patients with compensatory cirrhosis and without ascites;
(5) Patients with severe diseases of cardiovascular, kidney, hematopoietic system, nervous system, tumor disease and mental illness;
(6) Patients with gastrointestinal bleeding;
(7) Pregnant or lactating women.
Study & Design
- Study Type
- Treatment study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Curative effect index;Diagnostic indicators;
- Secondary Outcome Measures
Name Time Method Biological indicators;